Evelo Biosciences Earnings Date, Estimates & History

+0.30 (+3.26 %)
(As of 08/2/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume95,270 shs
Average Volume231,600 shs
Market Capitalization$507.59 million
P/E RatioN/A
Dividend YieldN/A

Evelo Biosciences (NASDAQ:EVLO) Earnings Information

Evelo Biosciences last announced its earnings data on July 28th, 2021. The reported ($0.53) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.54) by $0.01. Evelo Biosciences has generated ($2.37) earnings per share over the last year (($2.21) diluted earnings per share). Earnings for Evelo Biosciences are expected to grow in the coming year, from ($2.20) to ($1.92) per share. Evelo Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 4th, 2021 based off prior year's report dates.

Evelo Biosciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Evelo Biosciences (NASDAQ:EVLO) Earnings Estimates

2021 EPS Consensus Estimate: ($2.35)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.58)($0.58)($0.58)
Q2 20211($0.60)($0.60)($0.60)
Q3 20211($0.62)($0.62)($0.62)
Q4 20211($0.55)($0.55)($0.55)

Evelo Biosciences (NASDAQ EVLO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
2/13/2020Q4 2019($0.65)($0.70)($0.05)($0.70)    
11/5/2019Q3 2019($0.67)($0.67)($0.67)    
8/6/2019Q2 2019($0.6020)($0.65)($0.0480)($0.65)  
5/2/2019Q1 2019($0.55)($0.64)($0.09)($0.64)  
8/2/2018Q2 2018($0.3550)($0.85)($0.4950)($0.85)
5/31/2018Q1 2018($3.29)($3.29)($3.29)
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles

Evelo Biosciences (NASDAQ:EVLO) Earnings Frequently Asked Questions

When will Evelo Biosciences announce their next quarterly earnings?

Evelo Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 4th, 2021 based off last year's report dates. Learn more on EVLO's earnings history

When did Evelo Biosciences announce their last quarterly earnings?

Evelo Biosciences (NASDAQ:EVLO) last announced its quarterly earning data on Wednesday, July 28, 2021. Learn more on EVLO's earnings history

Did Evelo Biosciences beat their earnings estimates last quarter?

In the previous quarter, Evelo Biosciences (NASDAQ:EVLO) reported ($0.53) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.54) by $0.01. Learn more on EVLO's earnings details

How can I listen to Evelo Biosciences's earnings conference call?

The conference call for Evelo Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Evelo Biosciences's conference call transcript?

The conference call transcript for Evelo Biosciences's latest earnings report can be read online. Read Transcript

How can I view Evelo Biosciences's earnings report?

Evelo Biosciences's earnings report can be found in their filing with the SEC. View SEC filing

How much profit does Evelo Biosciences generate each year?

Evelo Biosciences (NASDAQ:EVLO) has a recorded net income of -$93.67 million. EVLO has generated -$2.37 earnings per share over the last four quarters.

What is Evelo Biosciences's EPS forecast for next year?

Evelo Biosciences's earnings are expected to grow from ($2.20) per share to ($1.92) per share in the next year.

This page was last updated on 8/3/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.